Home/ Stocks/ VTGN

Vistagen Therapeutics, Inc. Common Stock

VTGN XNAS

$0.63 -0.03 (-4.61%) ▼ 15-min delayed

Open

$0.65

High

$0.69

Low

$0.61

Volume

901.4K

Market Cap

$27.50M

About Vistagen Therapeutics, Inc. Common Stock

Vistagen Therapeutics Inc is a biotechnology firm. The company is neuroscience-focused biopharmaceutical company dedicated to pursuing a pioneering approach to the development and commercialization of groundbreaking therapies for psychiatric and neurological disorders based on deep understanding of nose-to-brain neurocircuitry.

Sector: PHARMACEUTICAL PREPARATIONS Employees: 41 Website →

Key Financials

Period	Revenue	Net Income	EPS
TTM 2026	$1.27M	$-69,685,000	$-1.83
FY 2026	$1.27M	$-69,685,000	$-1.83
Q3 2026	$303.0K	$-18,899,000	$-0.45
Q2 2026	$258.0K	$-19,417,000	$-0.54

Related Market News

No specific coverage for VTGN yet. Check out our latest market news or earnings calendar.

Get VTGN Alerts

Stay ahead with breaking news, price alerts, and expert analysis on Vistagen Therapeutics, Inc. Common Stock.

Disclaimer: This page is for informational purposes only. Stock data is delayed by at least 15 minutes. Always conduct your own research and consult with a qualified financial advisor before making investment decisions.